SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Aalami OO, Nacamuli RP, Lenton KA, Cowan CM, Fang TD, Fong KD, Shi YY, Song HM, Sahar DE, Longaker MT. 2004. Applications of a mouse model of calvarial healing: differences in regenerative abilities of juveniles and adults. Plast Reconstr Surg 114: 713720.
  • Anderson J, Lentz D, Johnson R. 1993. Recovery from disuse osteopenia coincident to restoration of muscle strength in mdx mice. Bone 14: 625634.
  • Aparicio LF, Jurkovic M, DeLullo J. 2002. Decreased bone density in ambulatory patients with Duchenne muscular dystrophy. J Pediatr Orthop 22: 179181.
  • Bianchi ML, Mazzanti A, Galbiati E, Saraifoger S, Dubini A, Cornelio F, Morandi L. 2003. Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos Int 14: 761767.
  • Biggar WD, Bachrach LK, Henderson RC, Kalkwarf H, Plotkin H, Wong BL. 2005. Bone health in Duchenne muscular dystrophy: a workshop report from the meeting in Cincinnati, Ohio, July 8, 2004. Neuromuscul Disord 15: 8085.
  • Briguet A, Courdier-Fruh I, Foster M, Meier T, Magyar JP. 2004. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul Disord 14: 675682.
  • Canalis E, Bilezikian JP, Angeli A, Giustina A. 2004. Perspectives on glucocorticoid-induced osteoporosis. Bone 34: 593598.
  • Chenu C, Colucci S, Grano M, Zigrino P, Barattolo R, Zambonin G, Baldini N, Vergnaud P, Delmas PD, Zallone AZ. 1994. Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J Cell Biol 127: 11491158.
  • Clarke B. 2008. Normal bone anatomy and physiology. Clin J Am Soc Nephrol 3: S131S139.
  • Cowan CM, Quarto N, Warren SM, Salim A, Longaker MT. 2003. Age-related changes in the biomolecular mechanisms of calvarial osteoblast biology affect fibroblast growth factor-2 signaling and osteogenesis. J Biol Chem 278: 3200532013.
  • D'Amore PA, Brown RH, Jr, Ku PT, Hoffman EP, Watanabe H, Arahata K, Ishihara T, Folkman J. 1994. Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann Neurol 35: 362365.
  • Evans NP, Misyak SA, Robertson JL, Bassaganya-Riera J, Grange RW. 2009. Dysregulated intracellular signaling and inflammatory gene expression during initial disease onset in Duchenne muscular dystrophy. Am J Phys Med Rehabil 88: 502522.
  • Gerstenfeld LC, Cho TJ, Kon T, Aizawa T, Tsay A, Fitch J, Barnes GL, Graves DT, Einhorn TA. 2003. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res 18: 15841592.
  • Glass GE, Chan JK, Freidin A, Feldmann M, Horwood NJ, Nanchahal J. 2011. TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc Natl Acad Sci USA 108: 15851590.
  • Gosain AK, Song L, Yu P, Mehrara BJ, Maeda CY, Gold LI, Longaker MT. 2000. Osteogenesis in cranial defects: reassessment of the concept of critical size and the expression of TGF-b isoforms. Plast Reconstr Surg 106: 360371.
  • Greenwald JA, Mehrara BJ, Spector JA, Chin GS, Steinbrech DS, Saadeh PB, Luchs JS, Paccione MF, Gittes GK, Longaker MT. 2000a. Biomolecular mechanisms of calvarial bone induction: immature versus mature dura mater. Plast Reconstr Surg 105: 13821392.
  • Greenwald JA, Mehrara BJ, Spector JA, Warren SM, Crisera FE, Fagenholz PJ, Bouletreau PJ, Longaker MT. 2000b. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: implications for suture fusion and patency. J Bone Miner Res 15: 24132430.
  • Grounds MD, Radley HG, Gebski BL, Bogoyevitch MA, Shavlakadze T. 2008. Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle. Clin Exp Pharmacol Physiol 35: 846851.
  • Grounds MD, Torrisi J. 2004. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J 18: 676682.
  • Hamrick MW, McNeil PL, Patterson SL. 2010. Role of muscle-derived growth factors in bone formation. J Musculoskelet Neuronal Interact 10: 6470.
  • Hashimoto J, Yoshikawa H, Takaoka K, Shimizu N, Masuhara K, Tsuda T, Miyamoto S, Ono K. 1989. Inhibitory effects of tumor necrosis factor alpha on fracture healing in rats. Bone 10: 453457.
  • Hsu JD. 1982. Skeletal changes in children with neuromuscular disorders. In: Dixon AD, Sarnat BG, editors. Factors and mechanisms influencing bone growth. New York: Alan R. Liss. p 553557.
  • Ishitobi M, Haginoya K, Zhao Y, Ohnuma A, Minato J, Yanagisawa T, Tanabu M, Kikuchi M, Iinuma K. 2000. Elevated plasma levels of transforming growth factor beta1 in patients with muscular dystrophy. NeuroReport 11: 40334035.
  • Karieb S, Fox SW. 2011. Phytoestrogens directly inhibit TNF-α-induced bone resorption in RAW264.7 cells by suppressing c-fos-induced NFATc1 expression. J Cell Biochem 112: 476487.
  • Kitaura H, Zhou P, Kim HJ, Novack DV, Ross FP, Teitelbaum SL. 2005. M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest 115: 34183427.
  • Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA. 2001. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16: 10041014.
  • Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106: 14811488.
  • Larson CM, Henderson RC. 2000. Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop 20: 7174.
  • McDonald DGM, Kinali M, Gallagher AC, Mercuri E, Muntoni F, Roper H, Jardine P, Jones DH, Pike MG. 2002. Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol 44: 695698.
  • Montgomery E, Pennington C, Isales CM, Hamrick MW. 2005. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice. Anat Rec A Discov Mol Cell Evol Biol 286: 814822.
  • Nakagaki WR, Bertran CA, Matsumura CY, Santo-Neto H, Camilli JA. 2011. Mechanical, biochemical and morphometric alterations in the femur of mdx mice. Bone 48: 372379.
  • Novotny SA, Warren GL, Lin AS, Guldberg RE, Baltgalvis KA, Lowe DA. 2011. Bone is functionally impaired in dystrophic mice but less so than skeletal muscle. Neuromuscul Disord 21: 183193.
  • Ochi S, Shinohara M, Sato K, Gober HJ, Koga T, Kodama T, Takai T, Miyasaka N, Takayanagi H. 2007. Pathological role of osteoclast costimulation in arthritis-induced bone loss. Proc Natl Acad Sci USA 104: 1139411399.
  • Pan Y, Chen C, Shen Y, Zhu CH, Wang G, Wang XC, Chen HQ, Zhu MS. 2008. Curcumin alleviates dystrophic muscle pathology in mdx mice. Mol Cells 25: 531537.
  • Pang L, Wu X, Lei W, Qiu T, Li F, Wan M, Cao X. 2010. IGF-I released during osteoclastic bone resorption induces osteoblast differentiation of BMSCs in the coupling process. J Bone Miner Res 25: S36.
  • Pastoret C, Sebille A. 1995. Mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 129: 97105.
  • Porter JD, Guo W, Merriam AP, Khanna S, Cheng G, Zhou X, Andrade FH, Richmonds C, Kaminski HJ. 2003a. Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle. Neuromuscul Disord 13: 223235.
  • Porter JD, Merriam AP, Leahy P, Gong B, Khanna S. 2003b. Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. Hum Mol Genet 12: 18131821.
  • Reed P, Bloch RJ. 2005. Postnatal changes in sarcolemmal organization in the mdx mouse. Neuromuscul Disord 15: 552561.
  • Rufo A, Del Fattore A, Bianchi ML, Morandi L, Bertini E, Musarò A, Ferrari S, Pierroz D, Capulli M, Rucci N, de Benedetti F, Teti A. 2009. Mechanisms inducing low bone density in Duchenne muscular dystrophy. Bone 44: S237S238.
  • Silva RV, Camilli JA. 2006. Repair of bone defects treated with autogenous bone graft and low-power laser. J Craniofac Surg 17: 297301.
  • Siperko LM, Landis WJ. 2001. Aspects of mineral structure in normally calcifying avian tendon. J Struct Biol 135: 313320.
  • Söderpalm AC, Magnusson P, Ahlander AC, Karlsson J, Kroksmark AK, Tulinius M, Swolin-Eide D. 2007. Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy. Neuromuscul Disord 17: 919928.
  • Straino S, Germani A, Di Carlo A, Porcelli D, de Mori R, Mangoni A, Napolitano M, Martelli F, Biglioli P, Capogrossi MC. 2004. Enhanced arteriogenesis and wound repair in dystrophin-deficient mdx mice. Circulation 110: 33413348.
  • Tanabe Y, Esaki K, Nomura T. 1986. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol 69: 9195.
  • Toti P, Villanova M, Vatti R, Schuerfeld K, Stumpo M, Barbagli L, Malandrini A, Costantini M. 2003. Nerve growth factor expression in human dystrophic muscles. Muscle Nerve 27: 370373.
  • Vestergaard P, Glerup H, Steffenson BF, Rejnmark L, Rahbeck J, Moseklide L. 2001. Fracture risk in patients with Duchenne muscular dystrophy and spinal muscular atrophy. J Rehab Med 33: 150155.
  • Vetrone SA, Montecino-Rodriguez E, Kudryashova E, Kramerova I, Hoffman EP, Liu SD, Miceli MC, Spencer MJ. 2009. Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. J Clin Invest 119: 15831594.
  • Wahl EC, Aronson J, Liu L, Fowlkes JL, Thrailkill KM, Bunn RC, Skinner RA, Miller MJ, Cockrell GE, Clark LM, Ou Y, Isales CM, Badger TM, Ronis MJ, Sims J, Lumpkin CK, Jr. 2010. Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF. J Bone Miner Res 25: 114123.
  • Yablonka-Reuveni Z, Anderson JE. 2006. Satellite cells from dystrophic (mdx) mice display accelerated differentiation in primary cultures and in isolated myofibers. Dev Dyn 235: 203212.
  • Young MF. 2003. Bone matrix proteins: their function, regulation, and relationship to osteoporosis. Osteoporos Int 14: S35S42.